Print Options

Card layout: ?

← Back to notecard set|Easy Notecards home page

Instructions for Side by Side Printing
  1. Print the notecards
  2. Fold each page in half along the solid vertical line
  3. Cut out the notecards by cutting along each horizontal dotted line
  4. Optional: Glue, tape or staple the ends of each notecard together
  1. Verify Front of pages is selected for Viewing and print the front of the notecards
  2. Select Back of pages for Viewing and print the back of the notecards
    NOTE: Since the back of the pages are printed in reverse order (last page is printed first), keep the pages in the same order as they were after Step 1. Also, be sure to feed the pages in the same direction as you did in Step 1.
  3. Cut out the notecards by cutting along each horizontal and vertical dotted line
To print: Ctrl+PPrint as a list

359 notecards = 90 pages (4 cards per page)

Viewing:

Chapter 9: Endocrine Physiology

front 1

(...) are secreted into the circulation in small amounts and delivered to target tissues, where they produce physiologic responses.

back 1

hormones

front 2

What are the nine classic endocrine glands?

back 2

  1. hypothalamus
  2. pituitary
  3. thyroid
  4. parathyroid
  5. adrenal cortex
  6. adrenal medulla
  7. gonads
  8. placenta
  9. pancreas

(The kidney also is considered to be an endocrine gland)

front 3

Hormones are categorized in one of three classes: (...).

back 3

peptides, steroids, or amines

front 4

Most hormones are classified as peptides; in the nucleus, the gene for the peptide hormone is transcribed into an (...).

back 4

mRNA

front 5

The mRNA for the peptide hormone is transferred to the cytoplasm and translated on the ribosomes to the first protein product, a (...).

back 5

preprohormone

front 6

The signal peptide is removed from the preprohormone in the endoplasmic reticulum, converting the it to a (...).

back 6

prohormone

front 7

The prohormone is transferred to the Golgi apparatus, where it is packaged in (...).

back 7

secretory vesicles

front 8

In the secretory vesicles, proteolytic enzymes cleave peptide sequences from the prohormone to produce the final (...).

back 8

hormone

front 9

The final hormone is stored in (...) until the endocrine cell is stimulated.

back 9

secretory vesicles

front 10

The steroid hormones are cortisol, aldosterone, estradiol and estriol, progesterone, testosterone, and 1,25-dihydroxycholecalciferol, which are derivatives of (...).

back 10

cholesterol

front 11

The amine hormones are catecholamines and thyroid hormones, which are derivatives of the amino acid (...).

back 11

tyrosine

front 12

Adjustments in secretory rates of hormones may be accomplished by (...) mechanisms or by (...) mechanisms.

back 12

neural; feedback

front 13

(...) mechanisms of hormone control are illustrated by the secretion of catecholamines.

back 13

neural

front 14

(...) mechanisms are the most common mechanism of hormone control.

back 14

feedback

front 15

(...) feedback means that some feature of hormone action inhibits further secretion of the hormone.

back 15

negative

front 16

(...) feedback means that the hormone feeds back all the way to the hypothalamic-pituitary axis.

back 16

long-loop

front 17

(...) feedback means that the anterior pituitary hormone feeds back on the hypothalamus.

back 17

short-loop

front 18

(...) feedback means that the hypothalamic hormone inhibits its own secretion.

back 18

ultrashort-loop

front 19

(...) feedback is an uncommon mechanism of hormone control in which some feature of hormone action causes more secretion of the hormone.

back 19

positive

front 20

The primary example of positive feedback is the effect of (...) on the secretion of gonadotropins by the anterior pituitary at the midpoint of the menstrual cycle.

back 20

estrogen

front 21

A second example of hormonal positive feedback is (...), which is secreted by the posterior pituitary in response to dilation of the cervix.

back 21

oxytocin

front 22

The responsiveness of a target tissue to a hormone is expressed in the (...) in which the magnitude of response is correlated with hormone concentration.

back 22

dose-response relationship

front 23

(...) is defined as the hormone concentration that produces 50% of the maximal response.

back 23

sensitivity

front 24

(...) means that the number or the affinity of the receptors for the hormone has decreased.

back 24

down-regulation

front 25

(...) means that the number or the affinity of the receptors for the hormone has increased.

back 25

up-regulation

front 26

The major mechanisms of hormone action on target cells are (1) the (...) mechanism, in which cAMP is the second messenger; (2) the (...) mechanism, in which IP3/Ca2+ is the second messenger; and (3) the (...) mechanism.

back 26

adenylyl cyclase; phospholipase C; steroid hormone

front 27

Insulin and insulin-like growth factors (IGFs) act on their target cells through a (...) mechanism.

back 27

tyrosine kinase

front 28

Several hormones activate (...), in which cyclic guanosine monophosphate is the second messenger.

back 28

guanylate cyclase

front 29

G proteins can be either stimulatory or inhibitory and are called, accordingly, (...).

back 29

Gs (stimulatory) or Gi (inhibitory)

front 30

When no hormone is bound to the receptor, the αs subunit of the Gs protein binds (...); In this configuration, the Gs protein is (...).

back 30

GDP; inactive

front 31

When hormone binds to its receptor in the cell membrane, (...) is released from the αs subunit and is replaced by (...), and the (...) detaches from the Gs protein.

back 31

GDP; GTP; αs subunit

front 32

The αs-GTP complex migrates within the cell membrane and binds to and activates (...).

back 32

adenylyl cyclase

front 33

Activated adenylyl cyclase catalyzes the conversion of adenosine triphosphate (ATP) to (...), which serves as the second messenger.

back 33

cAMP

front 34

cAMP, via a series of steps involving activation of (...), phosphorylates intracellular proteins.

back 34

protein kinase A

front 35

Intracellular cAMP is degraded to an inactive metabolite, (...), by the enzyme (...), thereby turning off the action of the second messenger.

back 35

5′ adenosine monophosphate (5′ AMP); phosphodiesterase

front 36

With no hormone bound to the receptor, the αq subunit binds (...); In this configuration, the Gq protein is (...).

back 36

GDP; inactive

front 37

When hormone binds to its receptor in the cell membrane, (...) is released from the αq subunit and is replaced by (...), and the (...) detaches from the Gq protein.

back 37

GDP; GTP; αq subunit

front 38

The αq-GTP complex migrates within the cell membrane and binds to and activates (...).

back 38

phospholipase C

front 39

Activated phospholipase C catalyzes the liberation of (...) and (...) from phosphatidylinositol 4,5-diphosphate (PIP2).

back 39

diacylglycerol; IP3

front 40

The IP3 causes the release of (...) from intracellular stores in the endoplasmic or sarcoplasmic reticulum.

back 40

Ca2+

front 41

Ca2+ and diacylglycerol activate (...), which phosphorylates proteins and produces the final physiologic actions.

back 41

protein kinase C

front 42

Some hormones bind to cell surface receptors called (...) that have, or are associated with, enzymatic activity on the intracellular side.

back 42

catalytic receptors

front 43

What are the four types of catalytic receptors?

back 43

  1. guanylyl cyclase
  2. serine/threonine kinases
  3. tyrosine kinases
  4. tyrosine kinase–associated receptors

front 44

Atrial natriuretic peptide (ANP) acts through a (...) mechanism.

back 44

receptor guanylyl cyclase

front 45

Nitric oxide (NO) acts through a (...) mechanism.

back 45

cytosolic guanylyl cyclase

front 46

(...) and (...) phosphorylate serine and threonine in the cascade of events leading to their biologic actions.

back 46

Ca2+-calmodulin-dependent protein kinase (CaMK); mitogen-activated protein kinases (MAPKs)

front 47

(...) have intrinsic tyrosine kinase activity within the receptor molecule; (...) do not have intrinsic tyrosine kinase activity but associate with proteins that do.

back 47

receptor tyrosine kinases; tyrosine kinase–associated receptors

front 48

The tyrosine kinase receptor for nerve growth factor (NGF) and epidermal growth factor receptors is a (...) which (...) after binding of ligand.

back 48

monomer; dimerizes

front 49

The tyrosine kinase receptor for insulin and insulin-like growth factor (IGF) is a already a (...).

back 49

dimer

front 50

The tyrosine kinase–associated receptor for growth hormone receptors is noncovalently “associated” with the (...) pathway.

back 50

JAK-STAT

front 51

In contrast to peptide hormones, steroid hormones and thyroid hormones bind to (...) receptors and have a (...) onset of action.

back 51

cytosolic (or nuclear); slower (taking hours)

front 52

The steroid hormone diffuses across the cell membrane, where it binds to a specific (...) that is located in either the cytosol or nucleus.

back 52

receptor protein

front 53

The steroid hormone binds in the (...) of the steroid receptor protein located near the C terminus.

back 53

E domain

front 54

The central (...) of the steroid receptor protein is highly conserved, has two zinc fingers, and is responsible for DNA binding.

back 54

C domain

front 55

The steroid hormone-receptor complex dimerizes and binds (at its C domain) via the zinc fingers to specific DNA sequences, called (...).

back 55

steroid-responsive elements (SREs)

front 56

After binding to the SRE, the hormone-receptor complex has now become a (...) that regulates the rate of transcription of that gene.

back 56

transcription factor

front 57

The posterior lobe (or posterior pituitary) of the hypothalamus is also called the (...).

back 57

neurohypophysis

front 58

The anterior lobe (or anterior pituitary) of the hypothalamus is also called the (...).

back 58

adenohypophysis

front 59

The hypothalamus is connected to the pituitary gland by a thin stalk called the (...).

back 59

infundibulum

front 60

The posterior lobe of the pituitary gland is derived from (...).

back 60

neural tissue

front 61

What are the two hormones secreted by the posterior pituitary?

back 61

  1. antidiuretic hormone (ADH)
  2. oxytocin

front 62

The hormones secreted by the posterior lobe are actually (...); in other words, they are peptides released from neurons.

back 62

neuropeptides

front 63

Although both posterior pituitary hormones are synthesized in both nuclei, ADH is primarily associated with (...) and oxytocin is primarily associated with (...).

back 63

supraoptic nuclei; paraventricular nuclei

front 64

Unlike the posterior lobe, which is neural tissue, the anterior lobe is primarily a collection of (...).

back 64

endocrine cells

front 65

What are the six hormones secreted by the anterior pituitary?

back 65

  1. thyroid-stimulating hormone (TSH)
  2. follicle-stimulating hormone (FSH)
  3. luteinizing hormone (LH)
  4. growth hormone (GH)
  5. prolactin
  6. adrenocorticotropic hormone (ACTH)

front 66

The hypothalamus and anterior pituitary are linked directly by the (...), which provide most of the blood supply of the anterior lobe.

back 66

hypothalamic-hypophysial portal blood vessels

front 67

What are the five major endocrine cell types of the anterior pituitary?

back 67

  1. somatotrophs (20%) secrete GH
  2. gonadotrophs (15%) secrete FSH and LH
  3. corticotrophs (15%) secrete ACTH
  4. lactotrophs (15%) secrete prolactin
  5. thyrotrophs (5%) secrete TSH

front 68

TSH, FSH, and LH are all (...) consisting of two subunits, α and β.

back 68

glycoproteins

front 69

The (...) of TSH, FSH, and LH are identical and are synthesized from the same mRNA.

back 69

α subunits

front 70

The (...) for TSH, FSH, and LH are different and therefore confer the biologic specificity.

back 70

β subunits

front 71

The placental hormone (...) is structurally related to the TSH-FSH-LH family.

back 71

human chorionic gonadotropin (HCG)

front 72

The ACTH family of hormones is derived from a single precursor, (...).

back 72

pro-opiomelanocortin (POMC)

front 73

In (...), POMC and ACTH levels are increased by negative feedback, and because of their MSH activity, skin pigmentation is a symptom of this disorder.

back 73

Addison disease (primary adrenal insufficiency)

front 74

(...) is secreted throughout life and is the single most important hormone for normal growth to adult stature.

back 74

growth hormone

front 75

Growth hormone is synthesized in the somatotrophs of the anterior lobe of the pituitary and also is called (...).

back 75

somatotropin

front 76

Human growth hormone is structurally similar to (...), containing 191 amino acids in a straight-chain polypeptide with 2 internal disulfide bridges.

back 76

prolactin

front 77

Growth hormone is secreted in a (...) pattern, with bursts of secretion occurring approximately every 2 hours.

back 77

pulsatile

front 78

At (...), there is an secretory burst of growth hormone, induced in females by estrogen and in males by testosterone.

back 78

puberty

front 79

(...) and (...) are potent stimuli for growth hormone secretion.

back 79

hypoglycemia; starvation

front 80

(...) acts directly on somatotrophs of the anterior pituitary to stimulate both synthesis and secretion of growth hormone.

back 80

GHRH

front 81

(...) is also secreted by the hypothalamus and acts on the somatotrophs to inhibit growth hormone secretion.

back 81

somatostatin (SRIF)

front 82

Growth hormone secretion is regulated by negative feedback: (1) GHRH is inhibited by (...); (2) growth hormone is inhibited by (...); (3) somatostatin is stimulated by (...).

back 82

GHRH (ultra-short loop); somatomedins; growth hormone and somatomedins

front 83

The direct actions of growth hormone are mediated by (...) receptors in skeletal muscle, the liver, or adipose tissue.

back 83

tyrosine kinase–associated

front 84

The indirect actions of growth hormone are mediated through the production of (...) in the liver, the most important of which is (...).

back 84

somatomedins (or IGFs); somatomedin C (or IGF-1)

front 85

Somatomedins act on target tissues through IGF receptors that are similar to the insulin receptor, having (...) activity.

back 85

intrinsic tyrosine kinase

front 86

What are the major actions of growth hormone? (3)

back 86

  1. diabetogenic or anti-insulin effect
  2. increased protein synthesis and organ growth
  3. increased linear growth

front 87

Growth hormone deficiency in children causes (...), including failure to grow, short stature, mild obesity, and delayed puberty.

back 87

dwarfism

front 88

One variant of dwarfism is (...), in which growth hormone levels are elevated due to a defect in the growth hormone receptors.

back 88

Laron dwarfism

front 89

Growth hormone excess causes (...) and is most often due to a growth hormone–secreting pituitary adenoma.

back 89

acromegaly

front 90

Before puberty, excessive levels of growth hormone cause (...) because of intense hormonal stimulation at the epiphyseal plates.

back 90

gigantism

front 91

Conditions with excess secretion of growth hormone are treated with (...), which inhibit growth hormone secretion by the anterior pituitary.

back 91

somatostatin analogues (e.g. octreotide)

front 92

(...) is the major hormone responsible for milk production and also participates in the development of the breasts.

back 92

prolactin

front 93

Chemically, prolactin is related to (...), having 198 amino acids in a single-chain polypeptide with 3 internal disulfide bridges.

back 93

growth hormone

front 94

In persons who are not pregnant or lactating, prolactin secretion is tonically inhibited by (...) from the hypothalamus.

back 94

dopamine (prolactin-inhibiting factor)

front 95

Prolactin inhibits its own secretion by increasing the synthesis and secretion of (...) from the hypothalamus.

back 95

dopamine

front 96

(...) and (...) are the most important stimuli for prolactin secretion.

back 96

pregnancy; breast-feeding (suckling)

front 97

What are the major actions of prolactin? (3)

back 97

  1. breast development
  2. lactogenesis (milk production)
  3. inhibition of ovulation

front 98

Prolactin inhibits ovulation by inhibiting the synthesis and release of (...), which accounts for the decreased fertility during breast-feeding.

back 98

gonadotropin-releasing hormone (GnRH)

front 99

Prolactin deficiency can be caused by total destruction of the (...) or selective destruction of (...).

back 99

destruction of the anterior pituitary; lactotrophs

front 100

Prolactin excess can be caused by destruction of the (...) or by prolactin- secreting tumors called (...).

back 100

destruction of the hypothalamus; prolactinomas

front 101

The major symptoms of excess prolactin secretion are (...) and (...).

back 101

galactorrhea; infertility

front 102

Whether the result of hypothalamic failure or a prolactinoma, prolactin excess can be treated by administration of (...), a dopamine agonist.

back 102

bromocriptine

front 103

ADH and oxytocin are homologous (...) (containing nine amino acids) synthesized in the supraoptic and paraventricular nuclei of the hypothalamus.

back 103

nonapeptides

front 104

The ADH neurons have their cell bodies primarily in the (...) nuclei of the hypothalamus.

back 104

supraoptic nuclei

front 105

The oxytocin neurons have their cell bodies primarily in (...) nuclei of the hypothalamus.

back 105

paraventricular

front 106

The peptide precursor for ADH is (...), which comprises a signal peptide, ADH, neurophysin II, and a glycoprotein.

back 106

prepropressophysin

front 107

The precursor for oxytocin is (...), which comprises a signal peptide, oxytocin, and neurophysin I.

back 107

prepro-oxyphysin

front 108

(...) is the major hormone concerned with regulation of body fluid osmolarity.

back 108

ADH (or vasopressin)

front 109

(...) is the most important physiologic stimulus for increasing ADH secretion.

back 109

increased plasma osmolarity

front 110

(...) is a potent stimulus for ADH secretion which overrides plasma osmolarity.

back 110

hypovolemia

front 111

What are the major actions of ADH? (2)

back 111

  1. increase in water reabsorption
  2. contraction of vascular smooth muscle

front 112

The receptor for ADH on the principal cells of the kidney is the (...) receptor, which is coupled to (...) via a G protein.

back 112

V2; adenylyl cyclase

front 113

The second messenger for the V2 receptor is (...), which, via phosphorylation steps, directs the insertion of (...) in the luminal membranes.

back 113

cAMP; aquaporin 2 (AQP2)

front 114

The receptor for ADH on vascular smooth muscle is the (...) receptor, which is coupled to (...) via a G protein.

back 114

V1; phospholipase C

front 115

The second messenger for the V1 receptor is (...), which produces (...) of vascular smooth muscle.

back 115

contraction; IP3/Ca2+

front 116

(...) is caused by failure of the posterior pituitary to secrete ADH; the collecting ducts are impermeable to water, and the urine cannot be concentrated.

back 116

central diabetes insipidus

front 117

Central diabetes insipidus is treated with an ADH analogue, (...).

back 117

desmopressin (dDAVP)

front 118

In (...), the posterior pituitary is normal but the principal cells of the collecting duct are unresponsive to ADH due to a defect in the V2 receptor.

back 118

nephrogenic diabetes insipidus

front 119

Nephrogenic diabetes insipidus is treated with (...).

back 119

thiazide diuretics

front 120

In (...), excess ADH is secreted from an autonomous site, such as oat cell carcinoma of the lung.

back 120

syndrome of inappropriate ADH (SIADH)

front 121

SIADH is treated with an ADH antagonist such as (...) or water restriction.

back 121

demeclocycline

front 122

(...) produces milk “letdown” or milk ejection from the lactating breast.

back 122

oxytocin

front 123

The major stimulus for oxytocin secretion is (...); however, (...) also cause milk letdown.

back 123

suckling; conditioned responses

front 124

What are the major actions of oxytocin? (2)

back 124

  1. milk ejection
  2. uterine contraction

front 125

Stimulation of powerful rhythmic contractions of uterine smooth muscle by oxytocin is the basis for its use in inducing (...) and in reducing (...).

back 125

labor; postpartum bleeding

front 126

The two active thyroid hormones are (...) and (...).

back 126

triiodothyronine (T3); thyroxine (T4)

front 127

Thyroid hormones are synthesized by the (...) cells of the thyroid gland.

back 127

follicular epithelial cells

front 128

The material in the lumen of the follicles is (...), which is composed of newly synthesized thyroid hormones attached to (...).

back 128

colloid; thyroglobulin (TG)

front 129

(...), a glycoprotein containing large quantities of tyrosine, is synthesized on the rough endoplasmic reticulum and the Golgi apparatus of the thyroid follicular cells.

back 129

thyroglobulin (TG)

front 130

(...) is actively transported from blood into the thyroid follicular epithelial cells against both chemical and electrical gradients via (...).

back 130

I− (iodide); Na+-I− cotransport

front 131

The anions (...) block Na+-I− cotransport into follicular cells and interfere with the synthesis of thyroid hormones.

back 131

thiocyanate and perchlorate

front 132

Once I− is pumped into the follicular epithelial cell, it is oxidized to (...) by the enzyme (...).

back 132

I2 (iodide); thyroid peroxidase

front 133

Thyroid peroxidase is inhibited by (...), which blocks the synthesis of thyroid hormones.

back 133

propylthiouracil (PTU)

front 134

At the apical membrane, I2 combines with the (...) moieties of TG, catalyzed by thyroid peroxidase, to form (...) and (...).

back 134

tyrosine; monoiodotyrosine (MIT); diiodotyrosine (DIT)

front 135

High levels of I− inhibit organification and synthesis of thyroid hormones, which is known as the (...).

back 135

Wolff-Chaikoff effect

front 136

While still part of TG, coupling reactions occur between MIT and DIT; either two molecules of DIT combine to form (...) or DIT combines with MIT to form (...).

back 136

thyroxine (T4); triiodothyronine (T3)

front 137

Iodinated TG is stored in the follicular lumen as (...) until the thyroid gland is stimulated to secrete its hormones (e.g., by TSH).

back 137

colloid

front 138

When the thyroid gland is stimulated, iodinated TG is (...) into the follicular epithelial cells.

back 138

endocytosed

front 139

(...) hydrolyze peptide bonds to release T4, T3, MIT, and DIT from TG.

back 139

lysosomal proteases

front 140

MIT and DIT are deiodinated inside the follicular cell by the enzyme (...), then are incorporated into the synthesis of new TG to begin another cycle.

back 140

thyroid deiodinase

front 141

Most T4 and T3 circulates bound to (...); because only free thyroid hormones are physiologically active, this provides a reservoir of hormones.

back 141

thyroxine-binding globulin (TBG)

front 142

In (...), blood levels of TBG decrease because there is decreased protein synthesis, resulting in a transient (...) in the level of free thyroid hormones.

back 142

hepatic failure; increase

front 143

During (...), high levels of estrogen inhibits hepatic breakdown of TBG, resulting in a transient (...) in the level of free thyroid hormones.

back 143

pregnancy; decrease

front 144

Circulating levels of TBG can be indirectly assessed with the (...), which measures the binding of radioactive T3 to a synthetic resin.

back 144

T3 resin uptake test

front 145

The major secretory product of the thyroid gland is (...), which is the less active form of thyroid hormone.

back 145

T4

front 146

In the target tissues, the enzyme (...) converts T4 to T3 by removing one atom of I2 from the outer ring of the molecule.

back 146

5′-iodinase

front 147

The target tissues also convert a portion of the T4 to an inactive form, (...), by removing one atom of I2 from the inner ring of the molecule.

back 147

reverse T3 (rT3)

front 148

(...) inhibits 5′-iodinase in tissues such as skeletal muscle, thus lowering O2 consumption and basal metabolic rate.

back 148

starvation

front 149

(...) acts on the thyrotrophs of the anterior pituitary to stimulate synthesis and secretion of TSH.

back 149

TRH

front 150

(...) regulates the growth of the thyroid gland (i.e. a trophic effect) and the secretion of thyroid hormones.

back 150

TSH

front 151

TSH secretion is regulated by two reciprocal factors: (1) (...) stimulates the secretion of TSH; (2) (...) inhibits the secretion of TSH by down-regulating the TRH receptor.

back 151

TRH; thyroid hormone (i.e. free T3)

front 152

The actions of TSH on the thyroid gland are initiated when TSH binds to a membrane receptor, which is coupled to (...) via a G protein.

back 152

adenylyl cyclase

front 153

Activation of adenylyl cyclase generates (...), which serves as the second messenger for TSH.

back 153

cAMP

front 154

The TSH receptor on the thyroid cells also is activated by (...), which are antibodies to the TSH receptor.

back 154

thyroid-stimulating immunoglobulins

front 155

(...), a common form of hyperthyroidism, is caused by increased circulating levels of thyroid-stimulating immunoglobulins.

back 155

Graves disease

front 156

The first step in the action of thyroid hormones in target tissues is (...).

back 156

conversion of T4 to T3 by 5′-iodinase

front 157

Once T3 is produced inside the target cells, it binds to a (...).

back 157

nuclear receptor

front 158

The T3-receptor complex then binds to a (...) on DNA, where it stimulates (...).

back 158

thyroid-regulatory element; DNA transcription

front 159

A vast array of new proteins are synthesized under the direction of thyroid hormones, including (...).

back 159

Na+-K+ ATPase

front 160

What are the major effects of thyroid hormones? (5)

back 160

  1. increase BMR
  2. increase metabolism
  3. increase in cardiac output
  4. stimulate growth and bone development
  5. essential for normal maturation of the CNS

front 161

Thyroid hormones increase oxygen consumption in all tissues except (...) by inducing the synthesis and increasing the activity of (...).

back 161

brain, gonads, and spleen; Na+-K+ ATPase

front 162

The cardiac effects of thyroid hormones are explained by the fact that they induce the synthesis of (...).

back 162

β1-adrenergic receptors

front 163

Many of the effects of thyroid hormones on BMR, heat production, heart rate, and stroke volume are similar to those produced by catecholamines via (...) receptors.

back 163

β-adrenergic

front 164

The most common form of hyperthyroidism is (...), an autoimmune disorder characterized by increased circulating levels of (...).

back 164

Graves disease; thyroid-stimulating immunoglobulins

front 165

The diagnosis of hyperthyroidism is based on symptoms and measurement of increased levels of (...).

back 165

T3 and T4

front 166

If the cause of hyperthyroidism is a disorder of the thyroid gland, then TSH levels will be (...).

back 166

decreased

front 167

If the cause of hyperthyroidism is a disorder of the hypothalamus or anterior pituitary, then TSH levels will be (...).

back 167

increased

front 168

What are the symptoms of hyperthyroidism? (10)

back 168

  1. increased basal metabolic rate
  2. weight loss
  3. negative nitrogen balance
  4. increased heat production
  5. sweating
  6. increased cardiac output
  7. dyspnea (shortness of breath)
  8. tremor, muscle weakness
  9. exophthalmos
  10. goiter

front 169

Treatment of hyperthyroidism includes (...), which inhibits the synthesis of thyroid hormones, surgical removal of the gland, or radioactive ablation with (...)

back 169

propylthiouracil: 131I−

front 170

The most common cause of hypothyroidism is (...) in which antibodies may either frankly destroy the gland or block thyroid hormone synthesis.

back 170

autoimmune destruction (thyroiditis)

front 171

The diagnosis of hypothyroidism is based on symptoms and a finding of decreased levels of (...).

back 171

T3 and T4

front 172

If the cause of hypothyroidism is a disorder of the thyroid gland, then TSH levels will be (...).

back 172

increased

front 173

If the cause of hypothyroidism is a disorder of the hypothalamus or anterior pituitary, then TSH levels will be (...).

back 173

decreased

front 174

What are the symptoms of hypothyroidism? (10)

back 174

  1. decreased basal metabolic rate
  2. weight gain
  3. positive nitrogen balance
  4. decreased heat production
  5. cold intolerance
  6. decreased cardiac output
  7. hypoventilation
  8. myxedema
  9. drooping eyelids
  10. goiter

front 175

In some cases of hypothyroidism, (...) develops, in which there is edema due to accumulation of osmotically active mucopolysaccharides in interstitial fluid.

back 175

myxedema

front 176

When the cause of hypothyroidism is a defect in the thyroid, a (...) develops from the unrelenting stimulation of the thyroid gland by TSH.

back 176

goiter

front 177

If hypothyroidism occurs in the perinatal period and is untreated, it results in an irreversible form of growth and mental retardation called (...).

back 177

cretinism

front 178

Treatment of hypothyroidism involves thyroid hormone replacement therapy, usually (...).

back 178

T4 (levothyroxine)

front 179

Which of the following conditions are associated with goiter?

  1. Graves disease
  2. TSH-secreting tumors
  3. factitious hyperthyroidism (ingestion of T4)
  4. autoimmune thyroiditis
  5. TSH deficiency
  6. I− deficiency

back 179

  1. In Graves disease, high levels of thyroid-stimulating immunoglobulins have a trophic effect on the thyroid gland to produce goiter.
  2. In cases of TSH-secreting tumors, increased levels of TSH will have a trophic effect on the thyroid gland to produce goiter.
  3. In factitious hyperthyroidism, increased thyroid hormones cause decreased TSH by negative feedback and there is no goiter
  4. In autoimmune thyroiditis, decreased thyroid hormones cause increased TSH by negative feedback and produces goiter.
  5. In cases of TSH deficiency, decreased levels of TSH cause decreased thyroid hormone secretion and no goiter.
  6. In I− deficiency, decreased synthesis of T4 and T3 increases TSH secretion by negative feedback to produce goiter.

front 180

The (...), which is in the inner zone of the adrenal gland that comprises 20% of the tissue, is of (...) origin and secretes (...).

back 180

adrenal medulla; neuroectodermal; catecholamines

front 181

The (...), which is in the outer zone of the adrenal gland that comprises 80% of the tissue, is of (...) origin and secretes (...).

back 181

adrenal cortex; mesodermal; adrenocortical steroids

front 182

The innermost zone of the adrenal cortex, called the (...), and the middle zone, called the (...), synthesize and secrete (...) and (...).

back 182

zona reticularis; zona fasciculata; glucocorticoids; adrenal androgens

front 183

The outermost zone of the adrenal cortex, called the (...), secretes (...).

back 183

zona glomerulosa; mineralocorticoids

front 184

All of the steroids of the adrenal cortex are chemical modifications of a basic steroid nucleus, which is illustrated in the structure of (...).

back 184

cholesterol

front 185

The (...), represented by cortisol, have a ketone group at carbon 3 (C3) and hydroxyl groups at C11 and C21.

back 185

glucocorticoids

front 186

The (...), represented by aldosterone, have a double-bond oxygen at C18.

back 186

mineralocorticoids

front 187

The (...), represented in the adrenal cortex by dehydroepiandrosterone (DHEA) and androstenedione, have a double-bond oxygen at C17.

back 187

androgens

front 188

The layers of the adrenal cortex are specialized to synthesize and secrete particular steroid hormones; the basis for this is the presence or absence of (...).

back 188

enzymes that catalyze modifications of the steroid nucleus

front 189

The precursor for all adrenocortical steroids is (...).

back 189

cholesterol

front 190

The enzymes catalyzing the conversion of cholesterol to active steroid hormones require (...), molecular oxygen, and NADPH.

back 190

cytochrome P-450

front 191

A flavoprotein enzyme called (...) and an iron-containing protein called (...) are intermediates in the transfer of hydrogen from NADPH to the cytochrome P-450 enzymes.

back 191

adrenodoxin reductase; adrenodoxin

front 192

The first step in the synthesis of all adrenocortical steroid hormones, conversion of cholesterol to pregnenolone, is catalyzed by (...).

back 192

cholesterol desmolase

front 193

Cholesterol desmolase, the rate-limiting enzyme in adrenocortical steroid hormone synthesis pathway, is stimulated by (...).

back 193

ACTH

front 194

The major glucocorticoid produced in humans is (...), which is synthesized in the (...).

back 194

cortisol; zonae fasciculata and reticularis

front 195

Cortisol is not the only steroid in the pathway with glucocorticoid activity; (...) is also a glucocorticoid.

back 195

corticosterone

front 196

(...) inhibits 11β-hydroxylase, the last step in cortisol synthesis.

back 196

metyrapone

front 197

(...) inhibits several steps in the pathway including cholesterol desmolase, the first step.

back 197

ketoconazole

front 198

(...) are androgenic steroids produced in the (...).

back 198

DHEA and androstenedione; zonae fasciculata and reticularis

front 199

Adrenal androgens have a ketone group at C17, thus they are also called (...).

back 199

17-ketosteroids

front 200

The major mineralocorticoid in the body is (...), which is synthesized only in the (...).

back 200

aldosterone; zona glomerulosa

front 201

The addition of the enzyme (...) in the zona glomerulosa allow the conversion of corticosterone to aldosterone.

back 201

aldosterone synthase

front 202

Aldosterone is not the only steroid with mineralocorticoid activity; (...) and (...) also have mineralocorticoid activity.

back 202

11-deoxycorticosterone (DOC); corticosterone

front 203

The synthesis and secretion of steroid hormones by the adrenal cortex depend on the stimulation of cholesterol desmolase by (...).

back 203

ACTH

front 204

The zonae fasciculata and reticularis, which secrete glucocorticoids and androgens, are under the exclusive control of the (...).

back 204

hypothalamic-pituitary axis

front 205

The zona glomerulosa, which secretes mineralocorticoids, depends on ACTH for the first step in steroid biosynthesis, but otherwise it is controlled via the (...).

back 205

renin-angiotensin-aldosterone system

front 206

An impressive feature of the regulation of cortisol secretion is its (...) nature and its (...) pattern.

back 206

pulsatile; diurnal (daily)

front 207

The secretion of glucocorticoids by the zonae fasciculata/reticularis is regulated exclusively by the (...).

back 207

hypothalamic-pituitary axis

front 208

(...) acts on the corticotrophs by an adenylyl cyclase/cAMP mechanism to cause secretion of ACTH into the bloodstream.

back 208

CRH

front 209

(...) activates cholesterol desmolase in the adrenal cortex and up-regulates transcrption of its own receptor.

back 209

ACTH

front 210

ACTH has a (...) secretory pattern that drives a parallel pattern of cortisol secretion.

back 210

pulsatile and diurnal

front 211

Negative feedback is exerted by cortisol at three points in the hypothalamic-pituitary axis: (1) it directly inhibits (...); (2) it indirectly inhibits CRH secretion by effects on (...); (3) it inhibits the action of CRH on the (...).

back 211

CRH secretion; hippocampal neurons; anterior pituitary

front 212

The (...) test is based on the negative feedback effects of cortisol on the CRH-ACTH axis.

back 212

dexamethasone suppression

front 213

When a low dose of dexamethasone is given to a healthy person, it inhibits (...).

back 213

ACTH secretion

front 214

The major use of the dexamethasone suppression test is in persons with (...).

back 214

hypercortisolism

front 215

If the cause of hypercortisolism is (...), a low dose of dexamethasone does not suppress cortisol secretion but a high dose of dexamethasone does.

back 215

ACTH-secreting tumor

front 216

If the cause of hypercortisolism is an (...), then neither low-dose nor high-dose dexamethasone suppresses cortisol secretion.

back 216

adrenal cortical tumor

front 217

The major con­trol of aldosterone secretion is via the (...).

back 217

renin–angiotensin II–aldosterone system

front 218

The mediator of mineralcorticoid secretion is (...), which increases the synthesis and secretion of aldosterone by stimulating cholesterol desmolase and aldosterone synthase.

back 218

angiotensin II

front 219

(...) is the enzyme that catalyzes the conversion of angiotensinogen to angiotensin I, which is inactive.

back 219

renin

front 220

(...) catalyzes the conversion of angiotensin I to angiotensin II, which then acts on the zona glomerulosa to stimulate aldosterone synthesis.

back 220

angiotensin-converting enzyme (ACE)

front 221

Increases in serum (...) concentration increase aldosterone secretion.

back 221

K+

front 222

What are the major actions of glucocorticoids? (7)

back 222

  1. stimulation of gluconeogenesis
  2. anti-inflammatory effects
  3. suppression of immune response
  4. maintain vascular responsiveness to catecholamines
  5. inhibition of bone formation
  6. increases in glomerular filtration rate (GFR)
  7. effects on CNS (e.g decreased REM sleep)

front 223

Glucocorticoids are essential for survival during (...) because they stimulate these gluconeogenic routes.

back 223

fasting

front 224

Cortisol interferes with the body's inflammatory response by (1) inducing synthesis of (...), an inhibitor of phospholipase A2; (2) inhibiting production of (...), and proliferation of T lymphocytes; and (3) inhibiting release of (...) and (...) from mast cells and platelets.

back 224

lipocortin; interleukin-2 (IL-2); histamine; serotonin

front 225

Aldosterone has three actions on the late distal tubule and collecting ducts:

  1. It increases (...) reabsorption.
  2. It increases (...) secretion.
  3. It increases (...) secretion.

back 225

Na+; K+; H+

front 226

Renal cells contain the enzyme (...), which converts high-affinity cortisol to low affinity cortisone to prevent it from dominating mineralocorticoid receptors.

back 226

11β-hydroxysteroid dehydrogenase

front 227

In (...), there is increased synthesis of adrenal androgens leading to masculinization in females and suppression of gonadal function in both males and females.

back 227

adrenogenital syndrome

front 228

In the adrenogenital syndromes, due to the overproduction of adrenal androgens, there will be increased urinary levels of (...).

back 228

17-ketosteroids

front 229

Cortisol promotes gluconeogenesis; therefore, excess levels produce (...) and deficits produce (...) upon fasting.

back 229

hyperglycemia; hypoglycemia

front 230

Aldosterone causes increased K+ secretion by the renal principal cells; thus excess causes (...) and deficiency causes (...).

back 230

hypokalemia; hyperkalemia

front 231

Because adrenal androgens have testosterone-like effects, in females, overproduction causes (...) and deficits result in (...).

back 231

masculinization; loss of pubic hair and libido

front 232

(...) is commonly caused by autoimmune destruction of all zones of the adrenal cortex, resulting in decreased synthesis of all adrenocortical hormones.

back 232

Addison disease (primary adrenocortical insufficiency)

front 233

Addison disease also is characterized by (...), particularly of the elbows, knees, nail beds, nipples, and areolae and on recent scars.

back 233

hyperpigmentation

front 234

Hyperpigmentation in Addison disease is a result of increased levels of (...).

back 234

ACTH (contains the α-MSH fragment)

front 235

Conditions of (...) occur when there is insufficient CRH or insufficient ACTH.

back 235

secondary adrenocortical insufficiency

front 236

(...) is the result of chronic excess of glucocorticoids due to overproduction by the adrenal cortex or exogenous administration.

back 236

Cushing syndrome

front 237

(...) is characterized by excess glucocorticoids, in which the cause is hypersecretion of ACTH from a pituitary adenoma.

back 237

Cushing disease

front 238

What are the symptoms of Cushing syndrome? (8)

back 238

  1. hyperglycemia
  2. muscle wasting (increased proteolysis)
  3. increased lipolysis and thin extremities
  4. central obesity, round face, buffalo hump
  5. poor wound healing
  6. osteoporosis, and
  7. striae (caused by a loss of connective tissue)
  8. virilization and menstrual disorders in females

front 239

The (...), in which a synthetic glucocorticoid is administered, can distinguish between Cushing syndrome and Cushing disease.

back 239

dexamethasone suppression test

front 240

In (...), because the tumor functions autonomously, cortisol secretion is not suppressed by either low- or high-dose dexamethasone.

back 240

Cushing syndrome

front 241

In (...), ACTH and cortisol secretion are suppressed by high-dose dexamethasone but not by low-dose dexamethasone.

back 241

Cushing disease

front 242

Treatment of Cushing syndrome includes administration of drugs such as (...), which block steroid hormone biosynthesis.

back 242

ketoconazole or metyrapone

front 243

Because of its different etiology, treatment of Cushing disease involves (...).

back 243

surgical removal of the ACTH-secreting tumor

front 244

(...) is caused by an aldosterone-secreting tumor.

back 244

Conn syndrome (primary hyperaldosteronism)

front 245

Treatment of Conn syndrome consists of administration of an aldosterone antagonist such as (...), followed by surgical removal of the tumor.

back 245

spironolactone

front 246

The most common enzymatic defect in the steroid hormone biosynthetic pathways is deficiency of (...), which belongs to a group of disorders called (...).

back 246

21β-hydroxylase; adrenogenital syndrome

front 247

Without 21β-hydroxylase, the adrenal cortex is unable to convert progesterone to (...) or 17-hydroxyprogesterone to (...).

back 247

DOC; 11-deoxycortisol (the adrenal cortex does not synthesize mineralocorticoids or glucocorticoids)

front 248

In 21β-hydroxylase deficiency, steroid intermediates will accumulate above the enzyme block and be shunted toward production of (...).

back 248

adrenal androgens (causes virilization in females)

front 249

In 21β-hydroxylase deficiency, elevated ACTH (via negative feedback) has a trophic effect on the adrenal cortex; thus the other name for this disorder is (...).

back 249

congenital adrenal hyperplasia

front 250

A less common congenital abnormality of the steroid hormone biosynthetic pathway is deficiency of (...).

back 250

17α-hydroxylase

front 251

Without 17α-hydroxylase, pregnenolone cannot be converted to (...) and progesterone cannot be converted to (...).

back 251

17-hydroxypreg­nenolone; 17-hydroxyprogesterone (neither gluco­corticoids nor adrenal androgens will be produced)

front 252

In this 17α-hydroxylase deficiency, steroid intermediates accumulate to the left of the enzyme block and will be shunted toward production of (...).

back 252

mineralocorticoids (causes hypertension, hypokalemia, and metabolic alkalosis)

front 253

The endocrine cells of the pancreas are arranged in clusters called the (...), which compose 1% to 2% of the pancreatic mass.

back 253

islets of Langerhans

front 254

The β cells compose 65% of the islet and secrete (...).

back 254

insulin

front 255

The α cells compose 20% of the islet and secrete (...).

back 255

glucagon

front 256

The delta (δ) cells compose 10% of the islet and secrete (...).

back 256

somatostatin

front 257

The remaining cells of the pancreatic islets secrete (...).

back 257

pancreatic polypeptide

front 258

Insulin is synthesized and secreted by the (...).

back 258

β cells

front 259

Insulin is a peptide hormone consisting of two straight chains designated as the (...) and (...).

back 259

A chain; B chain

front 260

The synthesis of insulin is directed by a gene on (...), a member of a superfamily of genes that encode related growth factors.

back 260

chromosome 11

front 261

The mRNA directs ribosomal synthesis of (...), which contains four peptides: a signal peptide, the A and B chains of insulin, and a connecting peptide (C peptide).

back 261

preproinsulin

front 262

The signal peptide is cleaved from preproinsulin early in the biosynthetic process, yielding (...)

back 262

proinsulin

front 263

Proinsulin is packaged in secretory granules on the Golgi apparatus, during which, proteases cleave the connecting peptide, yielding (...).

back 263

insulin

front 264

The secretion of (...) is the basis of a test for β cell function in persons with type I diabetes mellitus who are receiving injections of exogenous insulin.

back 264

C peptide (It is packaged with insulin and released in equimolar quantities)

front 265

The most important factor influencing the secretion of insulin by β cells is (...)

back 265

glucose

front 266

The β cell membrane contains (...), a specific transporter for glucose that moves glucose from the blood into the cell by facilitated diffusion

back 266

GLUT2

front 267

Once inside the cell, glucose is phosphorylated to glucose-6-phosphate by (...), and glucose-6-phosphate is subsequently oxidized.

back 267

glucokinase

front 268

Oxidation of glucose-6-phosphate generates (...), which appears to be the key factor that regulates insulin secretion.

back 268

ATP

front 269

When ATP levels inside the β cell increase, the ATP-sensitive (...) channels close, which depolarizes the β cell membrane.

back 269

K+

front 270

The depolarization of the β cell caused by closure of the K+ channels opens voltage-sensitive (...) channels.

back 270

Ca2+

front 271

Increases in intracellular Ca2+ concentration within the β cell causes exocytosis of the (...)-containing secretory granules

back 271

insulin

front 272

Oral glucose is a more powerful stimulant for insulin secretion than intravenous glucose because it stimulates the secretion of (...).

back 272

glucose-dependent insulinotropic peptide (GIP)

front 273

(...) activates a Gq protein coupled to phospholipase C, which leads to a rise in intracellular Ca2+, causing exocytosis of insulin.

back 273

glucagon

front 274

(...) inhibits the insulin-releasing mechanism that glucagon stimulates.

back 274

somatostatin

front 275

(...) treat type II diabetes mellitus by stimulating insulin release from β cells by closing the ATP-dependent K+ channels.

back 275

sulfonylureas (e.g. tolbutamide, glyburide)

front 276

The insulin receptor is a tetramer composed of two (...) and two (...), joined by disulfide bonds.

back 276

α subunits; β subunits

front 277

The (...) of the insulin receptor have intrinsic tyrosine kinase activity.

back 277

β subunits

front 278

Insulin binds to the (...) of the tetrameric insulin receptor, producing a conformational change in the receptor.

back 278

α subunits

front 279

The conformational change in the α subunits of the insulin receptor activates tyrosine kinase in the β subunits, which (...) presence of ATP.

back 279

autophosphorylate

front 280

Activated (...) on the β subunits phosphorylates several other proteins or enzymes that are involved in the physiologic actions of insulin.

back 280

tyrosine kinase

front 281

Insulin (...) its own receptor by decreasing the rate of synthesis and increasing the rate of degradation of the receptor.

back 281

down-regulates

front 282

What are the major actions of insulin? (4)

back 282

  1. decreases blood glucose concentration
  2. decreases blood fatty acid and ketoacid concentrations
  3. decreases blood amino acid concentration
  4. promotes K+ uptake into cells by stimulating Na+-K+ ATPase

front 283

The hypoglycemic action of insulin is the result of (1) it increasing glucose transport into target cells by increasing (...) (2) it promoting (...) in the liver and in muscle and inhibiting (...); (3) it inhibiting gluconeogenesis by increasing the production of (...).

back 283

GLUT4; glycogenesis; glycogenolysis; fructose 2,6-bisphosphate

front 284

Insulin also appears to have a direct effect on the hypothalamic (...) center independent of the changes it produces in blood glucose concentration.

back 284

satiety

front 285

(...) is caused by destruction of β cells, often as a result of an autoimmune process.

back 285

type I (insulin-dependent) diabetes mellitus

front 286

The increased levels of ketoacids in type I diabetes mellitus cause a form of metabolic acidosis called (...).

back 286

diabetic ketoacidosis (DKA)

front 287

In diabetes mellitus, the nonreabsorbed glucose in the renal tubules acts as an osmotic solute in urine, producing (...).

back 287

osmotic diuresis

front 288

(...) is often associated with obesity and is caused by down-regulation of insulin receptors in target tissues and insulin resistance.

back 288

type II (non–insulin-dependent) diabetes mellitus

front 289

(...) can be used to treat type II diabetes mellitus by stimulating pancreatic insulin secretion, while (...) up-regulate insulin receptors on target tissues.

back 289

sulfonylureas (e.g. tolbutamide or glyburide); biguanides (e.g. metformin)

front 290

Glucagon is synthesized and secreted by the (...) of the islets of Langerhans.

back 290

α cells

front 291

The major factor stimulating the secretion of glucagon is (...).

back 291

decreased blood glucose concentration

front 292

Glucagon secretion also is stimulated by the ingestion of protein, specifically by the amino acids (...) and (...).

back 292

arginine; alanine

front 293

Another factor stimulating glucagon secretion is (...), which is secreted from the gastrointestinal tract when protein or fat is ingested.

back 293

cholecystokinin (CCK)

front 294

The glucagon receptor is coupled to (...) via a G protein and second messenger is (...).

back 294

adenylyl cyclase; cAMP

front 295

What are the major actions of glucagon? (2)

back 295

  1. increases blood glucose concentration
  2. increases blood fatty acid and ketoacid concentrations

front 296

Glucagon increases the blood glucose concentration by (1) stimulating (...) and inhibiting (...); and (2) by increasing gluconeogenesis by decreasing the production of (...).

back 296

glycogenolysis; glycogenesis; fructose 2,6-bisphosphate

front 297

Pancreatic somatostatin is secreted by the (...) of the islets of Langerhans.

back 297

δ cells

front 298

Pancreatic somatostatin inhibits secretion of (...) via paracrine actions.

back 298

insulin and glucagon

front 299

The total Ca2+ concentration in blood is normally 10 mg/dL; (...) amounts to 50% of total Ca2+ and it is the only form that is biologically active.

back 299

free, ionized Ca2+

front 300

(...) is a decrease in the plasma Ca2+ concentration, which produces symptoms of hyperreflexia, spontaneous twitching, muscle cramps, and tingling and numbness.

back 300

hypocalcemia

front 301

Specific indicators of hypocalcemia include the (...), or twitching of the facial muscles elicited by tapping on the facial nerve, and the (...), which is carpopedal spasm upon inflation of a blood pressure cuff.

back 301

Chvostek sign; Trousseau sign

front 302

(...) is an increase in the plasma Ca2+ concentration, which produces symptoms of constipation, polyuria, polydipsia, hyporeflexia, lethargy, coma, and death.

back 302

hypercalcemia

front 303

Changes in plasma (...) concentration alter the total Ca2+ concentration in the same direction.

back 303

protein

front 304

Changes in plasma (...) concentration alter the ionized Ca2+ concentration by changing the fraction of complexed Ca2+.

back 304

anion

front 305

(...) abnormalities alter the ionized Ca2+ concentration by changing the fraction of Ca2+ bound to plasma albumin.

back 305

acid-base

front 306

In (...), there is more H+ in blood to bind to albumin, leaving fewer sites for Ca2+ to bind, thus the free ionized Ca2+ concentration (...).

back 306

acidemia; increases

front 307

In (...), there is less H+ in blood to bind to albumin, leaving more sites for Ca2+ to bind, thus the free ionized Ca2+ concentration (...).

back 307

alkalemia; decreases

front 308

What three organ systems are involved in Ca2+ homeostasis?

back 308

bone, kidney, and intestine

front 309

The (...) of the parathyroid glands synthesize and secrete PTH.

back 309

chief cells

front 310

PTH secretion is regulated by plasma (...) concentration; when it decreases to less than (...), PTH secretion is stimulated.

back 310

Ca2+; 10 mg/dL

front 311

The parathyroid cell membrane contains (...) that are linked, via a G protein to phospholipase C.

back 311

Ca2+ sensing receptors

front 312

Chronic (...) causes (...), which is characterized by increased synthesis and storage of PTH and hyperplasia of the parathyroid glands.

back 312

hypocalcemia; secondary hyperparathyroidism

front 313

Chronic (...) causes decreased synthesis and storage of PTH, increased breakdown of stored PTH, and release of inactive PTH fragments into the circulation.

back 313

hypercalcemia

front 314

(...) has parallel, although less important, effects on PTH secretion as Ca2+.

back 314

Mg2+

front 315

The receptor for PTH is coupled, via a G protein, to (...).

back 315

adenylyl cyclase

front 316

In bone, PTH receptors are located only on (...).

back 316

osteoblasts

front 317

Initially and transiently, PTH causes (...) by a direct action on osteoblasts.

back 317

increased bone formation

front 318

In a second, long-lasting, indirect action on osteoclasts, PTH causes (...), mediated by (...) released from osteoblasts.

back 318

increased bone resorption; cytokines

front 319

PTH inhibits (...) reabsorption in the proximal convoluted tubule.

back 319

phosphate (causes phosphaturia)

front 320

The cAMP generated in cells of the proximal tubule is excreted in urine and is called (...).

back 320

nephrogenous or urinary cAMP

front 321

The phosphaturic action of PTH is critical because otherwise the phosphate resorbed from bone would (...).

back 321

complex Ca2+ in ECF

front 322

PTH stimulates (...) reabsorption in the proximal convoluted tubule.

back 322

Ca2+

front 323

PTH does not have direct actions on the small intestine, although indirectly it stimulates intestinal Ca2+ absorption via (...).

back 323

activation of vitamin D

front 324

Primary hyperparathyroidism is most commonly caused by (...).

back 324

parathyroid adenomas (tumors)

front 325

In primary hyperparathyroidism, (...) results from increased bone re­­sorption, increased renal Ca2+ reabsorption, and increased intestinal Ca2+ absorption.

back 325

hypercalcemia

front 326

In primary hyperparathyroidism, (...) results from decreased renal phosphate reabsorption and phosphaturia.

back 326

hypophosphatemia

front 327

Persons with primary hyperparathyroidism are said to have "(...)."

back 327

“stones, bones, and groans” (stones from hypercalciuria, bones from increased bone resorption, and groans from constipation)

front 328

In secondary hyperparathyroidism, the parathyroid glands are stimulated to secrete excessive PTH secondary to (...), which can be caused by (...).

back 328

hypocalcemia; vitamin D deficiency or chronic renal failure

front 329

(...) is a relatively common, inadvertent consequence of thyroid surgery or parathyroid surgery.

back 329

hypoparathyroidism

front 330

In hypoparathyroidism, (...) results from decreased bone resorption, decreased renal Ca2+ reabsorption, and decreased intestinal Ca2+ absorption.

back 330

hypocalcemia

front 331

In hypoparathyroidism, (...) results from increased phosphate reabsorption.

back 331

hyperphosphatemia

front 332

Patients with (...) have hypocalcemia and hyperphosphatemia; however, circulating levels of PTH are increased rather than decreased.

back 332

pseudohypoparathyroidism

front 333

Pseudohypoparathyroidism is an inherited autosomal dominant disorder in which the (...) for PTH in kidney and bone is defective.

back 333

Gs protein

front 334

Some malignant tumors secrete (...), which is structurally homologous with the PTH secreted by the parathyroid glands, with all the same physiologic actions.

back 334

PTH-related peptide (PTH-rp)

front 335

Humoral hypercalcemia of malignancy is treated with (...), which inhibits renal Ca2+ reabsorption, and inhibitors of bone resorption such as (...).

back 335

furosemide; etidronate

front 336

(...) is an autosomal dominant disorder characterized by decreased urinary Ca2+ excretion and increased serum Ca2+ concentration.

back 336

familial hypocalciuric hypercalcemia (FHH)

front 337

FHH is caused by inactivating mutations of (...) in the parathyroid glands and the thick, ascending limb of the kidney.

back 337

Ca2+ sensing receptors

front 338

Calcitonin is synthesized and secreted by the (...) of the thyroid gland.

back 338

parafollicular or C cells

front 339

The major stimulus for calcitonin secretion is (...).

back 339

increased plasma Ca2+ concentration

front 340

The major action of calcitonin is to (...), which decreases the plasma Ca2+ concentration.

back 340

inhibit bone resorption

front 341

(...) in conjunction with PTH, is the second major regulatory hormone for Ca2+ and phosphate metabolism.

back 341

vitamin D

front 342

Vitamin D in the form of (...) is provided in the diet and is produced in the skin from cholesterol.

back 342

cholecalciferol

front 343

Cholecalciferol is physiologically inactive; it is hydroxylated in the liver to form (...), which also is inactive.

back 343

25-hydroxycholecalciferol

front 344

In the kidney, 25-hydroxycholecalciferol (1) can be hydroxylated at C1 to produce (...), the active form, or (2) can be hydroxylated at C24 to produce (...), which is inactive.

back 344

1,25-dihydroxycholecalciferol; 24,25-dihydroxycholecalciferol

front 345

C1 hydroxylation of 25-hydroxycholecalciferol in the kidney is catalyzed by the enzyme (...).

back 345

1α-hydroxylase

front 346

1α-hydroxylase activity is stimulated by(1) decreased plasma (...) concentration, (2) increased circulating levels of (...), and (3) decreased plasma (...) concentration.

back 346

Ca2+; PTH; phosphate

front 347

The overall role of 1,25-dihydroxycholecalciferol is to increase the plasma concentration of (...) to promote (...).

back 347

Ca2+ and phosphate; mineralization of new bone

front 348

In the intestine, 1,25-dihydroxycholecalciferol induces the synthesis of a vitamin D–dependent Ca2+-binding protein called (...).

back 348

calbindin D-28K

front 349

The actions of 1,25-dihydroxycholecalciferol on the kidney are parallel to its actions on the intestine—it stimulates (...).

back 349

Ca2+ and phosphate reabsorption

front 350

In bone, 1,25-dihydroxycholecalciferol acts synergistically with PTH to stimulate (...).

back 350

bone resorption (“old” bone is resorbed to provide Ca2+ and phosphate so that “new” bone can be mineralized)

front 351

In children, vitamin D deficiency causes (...), a condition in which insufficient amounts of Ca2+ and phosphate are available to mineralize the growing bones.

back 351

rickets

front 352

In adults, vitamin D deficiency results in (...), in which new bone fails to mineralize, resulting in bending and softening of the weight-bearing bones.

back 352

osteomalacia

front 353

(...) occurs when the kidney is unable to produce the active metabolite, 1,25-dihydroxycholecalciferol.

back 353

vitamin D resistance

front 354

Vitamin D resistance can be caused by the congenital absence of 1α-hydroxylase or, more commonly, by (...).

back 354

chronic renal failure

front 355

back 355

no data

front 356

back 356

no data

front 357

back 357

no data

front 358

back 358

no data

front 359

back 359

no data